The principles of wound healing

References

• Kondo T, Ishida Y. Molecular pathology of wound healing. Forensic. Sci. Int. 203(1–3), 93–98 (2010).
   PubMed Web of Science ®Google Scholar
• Lorenz HP, Longaker MT. Essential Practice of Surgery: Wounds: Biology, Pathology, and Management. Springer, New York, NY, USA (2003).
   Google Scholar
• Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front. Biosci. 9, 283–289 (2004).
   PubMed Web of Science ®Google Scholar
• Ishida Y, Kondo T, Kimura A, Matsushima K, Mukaida N. Absence of IL-1 receptor antagonist impaired wound healing along with aberrant NF-kappaB activation and a reciprocal suppression of TGF-beta signal pathway. J. Immunol. 176(9), 5598–5606 (2006).
   PubMed Web of Science ®Google Scholar
• Schiro JA, Chan BM, Roswit WT et al. Integrin alpha 2 beta 1 (VLA-2) mediates reorganization and contraction of collagen matrices by human cells. Cell 67(2), 403–410 (1991).
   PubMedGoogle Scholar
• Langholz O, Rockel D, Mauch C et al. Collagen and collagenase gene expression in three-dimensional collagen lattices are differentially regulated by alpha 1 beta 1 and alpha 2 beta 1 integrins. J. Cell Biol. 131(6 Pt 2), 1903–1915 (1995.).
   PubMedGoogle Scholar
• Eckes B, Zweers MC, Zhang ZG et al. Mechanical tension and integrin alpha 2 beta 1 regulate fibroblast functions. J. Investig. Dermatol. Symp. Proc. 11(1), 66–72 (2006).
   PubMedGoogle Scholar
• Wang Z, Fong KD, Phan TT, Lim IJ, Longaker MT, Yang GP. Increased transcriptional response to mechanical strain in keloid fibroblasts due to increased focal adhesion complex formation. J. Cell. Physiol. 206(2), 510–517 (2006).
   PubMedGoogle Scholar
• Huang C, Akaishi S, Ogawa R. Mechanosignaling pathways in cutaneous scarring. Arch. Dermatol. Res. 304(8), 589–597 (2012).
   PubMedGoogle Scholar
• Occleston NL, O'Kane S, Laverty HG et al. Discovery and development of avotermin (recombinant human transforming growth factor beta 3): a new class of prophylactic therapeutic for the improvement of scarring. Wound Repair Regen. 19( Suppl. 1), s38–s48 (2011).
   PubMedGoogle Scholar
• Ohno S, Hirano S, Kanemaru S et al. Prevention of buccal mucosa scarring with transforming growth factor beta3. Laryngoscope 121(7), 1404–1409 (2011).
   PubMedGoogle Scholar
• Shah M, Foreman DM, Ferguson MW. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J. Cell Sci. 108(Pt 3), 985–1002 (1995).
   PubMedGoogle Scholar
• Niethammer P, Grabher C, Look AT, Mitchison TJ. A tissue-scale gradient of hydrogen peroxide mediates rapid wound detection in zebrafish. Nature 459(7249), 996–999 (2009).
   PubMed Web of Science ®Google Scholar
• Yoo SK, Starnes TW, Deng Q, Huttenlocher A. Lyn is a redox sensor that mediates leukocyte wound attraction in vivo. Nature 480(7375), 109–112 (2011).
   PubMedGoogle Scholar
• Guo S, Dipietro LA. Factors affecting wound healing. J. Dent. Res. 89(3), 219–229 (2010).
   PubMed Web of Science ®Google Scholar
• Artuc M, Steckelings UM, Henz BM. Mast cell-fibroblast interactions: human mast cells as source and inducers of fibroblast and epithelial growth factors. J. Invest. Dermatol. 118(3), 391–395 (2002).
   PubMedGoogle Scholar
• Ishida Y, Gao JL, Murphy PM. Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J. Immunol. 180(1), 569–579 (2008).
   PubMed Web of Science ®Google Scholar
• Ishida Y, Kimura A, Kuninaka Y et al. Pivotal role of the CCL5/CCR5 interaction for recruitment of endothelial progenitor cells in mouse wound healing. J. Clin. Invest. 122(2), 711–721 (2012).
   PubMedGoogle Scholar
• Schreml S, Szeimies RM, Prantl L, Landthaler M, Babilas P. Wound healing in the 21st century. J. Am. Acad. Dermatol. 63(5), 866–881 (2010).
   PubMed Web of Science ®Google Scholar
• Yukami T, Hasegawa M, Matsushita Y et al. Endothelial selectins regulate skin wound healing in cooperation with L-selectin and ICAM-1. J. Leukoc. Biol. 82(3), 519–531 (2007).
   PubMedGoogle Scholar
• Nagaoka T, Kaburagi Y, Hamaguchi Y et al. Delayed wound healing in the absence of intercellular adhesion molecule-1 or L-selectin expression. Am. J. Pathol. 157(1), 237–247 (2000).
   PubMed Web of Science ®Google Scholar
• Tomita H, Iwata Y, Ogawa F et al. P-selectin glycoprotein ligand-1 contributes to wound healing predominantly as a p-selectin ligand and partly as an e-selectin ligand. J. Invest. Dermatol. 129(8), 2059–2067 (2009).
   PubMedGoogle Scholar
• Reddy BY, Jow T, Hantash BM. Bioactive oligopeptides in dermatology: Part II. Exp. Dermatol. 21(8), 569–575 (2012).
   PubMedGoogle Scholar
• Zheng Y, Niyonsaba F, Ushio H et al. Cathelicidin LL-37 induces the generation of reactive oxygen species and release of human alpha-defensins from neutrophils. Br. J. Dermatol. 157(6), 1124–1131 (2007).
   PubMed Web of Science ®Google Scholar
• Hoq MI, Niyonsaba F, Ushio H, Aung G, Okumura K, Ogawa H. Human catestatin enhances migration and proliferation of normal human epidermal keratinocytes. J. Dermatol. Sci. 64(2), 108–118 (2011).
   PubMedGoogle Scholar
• Macedo L, Pinhal-Enfield G, Alshits V, Elson G, Cronstein BN, Leibovich SJ. Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors. Am. J. Pathol. 171(6), 1774–1788 (2007).
   PubMed Web of Science ®Google Scholar
• De Falco E, Porcelli D, Torella AR et al. SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104(12), 3472–3482 (2004).
   PubMedGoogle Scholar
• Asai J, Takenaka H, Kusano KF et al. Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodeling. Circulation 113(20), 2413–2424 (2006).
   PubMedGoogle Scholar
• Ekstrand AJ, Cao R, Bjorndahl M et al. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc. Natl Acad. Sci. USA 100(10), 6033–6038 (2003).
   PubMedGoogle Scholar
• Wulff BC, Parent AE, Meleski MA, DiPietro LA, Schrementi ME, Wilgus TA. Mast cells contribute to scar formation during fetal wound healing. J. Invest. Dermatol. 132(2), 458–465 (2012).
   PubMed Web of Science ®Google Scholar
• Saito S, Takayama Y, Mizumachi K, Suzuki C. Lactoferrin promotes hyaluronan synthesis in human dermal fibroblasts. Biotechnol Lett. 33(1), 33–39 (2011).
   Google Scholar
• Diegelmann RF. Cellular and biochemical aspects of normal and abnormal wound healing: an overview. J. Urol. 157(1), 298–302 (1997).
   PubMedGoogle Scholar
• Watterson KR, Lanning DA, Diegelmann RF, Spiegel S. Regulation of fibroblast functions by lysophospholipid mediators: potential roles in wound healing. Wound Repair Regen. 15(5), 607–616 (2007).
   PubMed Web of Science ®Google Scholar
• Chavez-Munoz C, Hartwell R, Jalili RB et al. SPARC/SFN interaction, suppresses type I collagen in dermal fibroblasts. J. Cell Biochem. 113(8), 2622–2632 (2012).
   PubMedGoogle Scholar
• Workman G, Sage EH. Identification of a sequence in the matricellular protein SPARC that interacts with the scavenger receptor stabilin-1. J. Cell Biochem. 112(4), 1003–1008 (2011).
   PubMedGoogle Scholar
• Bamberger C, Hafner A, Schmale H, Werner S. Expression of different p63 variants in healing skin wounds suggests a role of p63 in reepithelialization and muscle repair. Wound Repair Regen. 13(1), 41–50 (2005).
   PubMedGoogle Scholar
• Ichikawa T, Suenaga Y, Koda T, Ozaki T, Nakagawara A. DeltaNp63/BMP-7-dependent expression of matrilin-2 is involved in keratinocyte migration in response to wounding. Biochem. Biophys. Res. Commun. 369(4), 994–1000 (2008).
   PubMedGoogle Scholar
• Zhang M, Liu NY, Wang XE et al. Activin B promotes epithelial wound healing in vivo through RhoA-JNK signaling pathway. PLoS ONE 6(9), e25143 (2011).
   Google Scholar
• Sarrazy V, Billet F, Micallef L, Coulomb B, Desmouliere A. Mechanisms of pathological scarring: role of myofibroblasts and current developments. Wound Repair Regen. 19( Suppl. 1), s10–s15 (2011).
   PubMedGoogle Scholar
• Aarabi S, Bhatt KA, Shi Y et al. Mechanical load initiates hypertrophic scar formation through decreased cellular apoptosis. FASEB J. 21(12), 3250–3261 (2007).
   PubMed Web of Science ®Google Scholar
• Gurtner GC, Dauskardt RH, Wong VW et al. Improving cutaneous scar formation by controlling the mechanical environment: large animal and phase I studies. Ann. Surg. 254(2), 217–225 (2011).
   PubMed Web of Science ®Google Scholar
• Kippenberger S, Bernd A, Loitsch S et al. Signaling of mechanical stretch in human keratinocytes via MAP kinases. J. Invest. Dermatol. 114(3), 408–412 (2000).
   PubMedGoogle Scholar
• Yano S, Komine M, Fujimoto M, Okochi H, Tamaki K. Mechanical stretching in vitro regulates signal transduction pathways and cellular proliferation in human epidermal keratinocytes. J. Invest. Dermatol. 122(3), 783–790 (2004).
   PubMedGoogle Scholar
• Connelly JT, Gautrot JE, Trappmann B et al. Actin and serum response factor transduce physical cues from the microenvironment to regulate epidermal stem cell fate decisions. Nat. Cell Biol. 12(7), 711–718 (2010).
   PubMed Web of Science ®Google Scholar
• Evans ND, Oreffo RO, Healy E, Thurner PJ, Man YH. Epithelial mechanobiology, skin wound healing, and the stem cell niche. J. Mech. Behav. Biomed. Mater. doi:10.1016/j.jmbbm.2013.04.023 (2013) ( Epub ahead of print).
   Google Scholar
• Santoro MM, Gaudino G. Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp. Cell Res. 304(1), 274–286 (2005).
   PubMed Web of Science ®Google Scholar
• Nikolopoulos SN, Blaikie P, Yoshioka T et al. Targeted deletion of the integrin beta4 signaling domain suppresses laminin-5-dependent nuclear entry of mitogen-activated protein kinases and NF-kappaB, causing defects in epidermal growth and migration. Mol. Cell Biol. 25(14), 6090–6102 (2005).
   PubMedGoogle Scholar
• Echtermeyer F, Streit M, Wilcox-Adelman S et al. Delayed wound repair and impaired angiogenesis in mice lacking syndecan-4. J. Clin. Invest. 107(2), R9–R14 (2001).
   PubMed Web of Science ®Google Scholar
• Inada R, Matsuki M, Yamada K et al. Facilitated wound healing by activation of the Transglutaminase 1 gene. Am. J. Pathol. 157(6), 1875–1882 (2000).
   PubMedGoogle Scholar
• Lin MP, Marti GP, Dieb R et al. Delivery of plasmid DNA expression vector for keratinocyte growth factor-1 using electroporation to improve cutaneous wound healing in a septic rat model. Wound Repair Regen. 14(5), 618–624 (2006).
   PubMedGoogle Scholar
• Gendronneau G, Sidhu SS, Delacour D et al. Galectin-7 in the control of epidermal homeostasis after injury. Mol. Biol. Cell 19(12), 5541–5549 (2008).
   PubMed Web of Science ®Google Scholar
• Cao Z, Said N, Amin S et al. Galectins-3 and -7, but not galectin-1, play a role in re-epithelialization of wounds. J. Biol. Chem. 277(44), 42299–42305 (2002).
   PubMed Web of Science ®Google Scholar
• Mustoe TA, Cooter RD, Gold MH et al. International clinical recommendations on scar management. Plast. Reconstr, Surg. 110(2), 560–571 (2002).
   PubMed Web of Science ®Google Scholar
• Stroncek JD, Reichert WM. Overview of wound healing in different tissue types. In: Indwelling Neural Implants: Strategies for Contending with the In Vivo Environment. Reichert WM ( Ed.). CRC Press, Boca Raton, FL, USA (2008).
   Google Scholar
• Fonder MA, Lazarus GS, Cowan DA, Aronson-Cook B, Kohli AR, Mamelak AJ. Treating the chronic wound: a practical approach to the care of nonhealing wounds and wound care dressings. J. Am. Acad. Dermatol. 58(2), 185–206 (2008).
   PubMed Web of Science ®Google Scholar
• Illman SA, Lohi J, Keski-Oja J. Epilysin (MMP-28)--structure, expression and potential functions. Exp. Dermatol. 17(11), 897–907 (2008).
   PubMedGoogle Scholar
• Illman SA, Lehti K, Keski-Oja J, Lohi J. Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells. J. Cell Sci. 119(Pt 18), 3856–3865 (2006).
   PubMed Web of Science ®Google Scholar
• Rayment EA, Upton Z, Shooter GK. Increased matrix metalloproteinase-9 (MMP-9) activity observed in chronic wound fluid is related to the clinical severity of the ulcer. Br. J. Dermatol. 158(5), 951–961 (2008).
   PubMed Web of Science ®Google Scholar
• Han YP, Yan C, Garner WL. Proteolytic activation of matrix metalloproteinase-9 in skin wound healing is inhibited by alpha-1-antichymotrypsin. J. Invest. Dermatol. 128(9), 2334–2342 (2008).
   PubMedGoogle Scholar
• Jansen PL, Rosch R, Jansen M et al. Regulation of MMP-2 gene transcription in dermal wounds. J. Invest. Dermatol. 127(7), 1762–1767 (2007).
   PubMedGoogle Scholar
• Heiskanen TJ, Illman SA, Lohi J, Keski-Oja J. Epilysin (MMP-28) is deposited to the basolateral extracellular matrix of epithelial cells. Matrix Biol. 28(2), 74–83 (2009).
   PubMedGoogle Scholar
• Swingler TE, Kevorkian L, Culley KL et al. MMP28 gene expression is regulated by Sp1 transcription factor acetylation. Biochem. J. 427(3), 391–400 (2010).
   PubMedGoogle Scholar
• Wolfram D, Tzankov A, Pulzl P, Piza-Katzer H. Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management. Dermatol. Surg. 35(2), 171–181 (2009).
   PubMed Web of Science ®Google Scholar
• Oliveira GV, Hawkins HK, Chinkes D et al. Hypertrophic versus non hypertrophic scars compared by immunohistochemistry and laser confocal microscopy: type I and III collagens. Int. Wound J. 6(6), 445–452 (2009).
   PubMedGoogle Scholar
• Qiu L, Jin XQ, Xiang DL, Fu YX, Tian XF. [Study on the collagen constitution of hyperplastic scar in different ages and its influencing factors]. Zhonghua Shao Shang Za Zhi. 19(4), 236–240 (2003).
   PubMedGoogle Scholar
• Friedman DW, Boyd CD, Mackenzie JW, Norton P, Olson RM, Deak SB. Regulation of collagen gene expression in keloids and hypertrophic scars. J. Surg. Res. 55(2), 214–222 (1993).
   PubMedGoogle Scholar
• Wankell M, Munz B, Hubner G et al. Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis. EMBO J. 20(19), 5361–5372 (2001).
   PubMedGoogle Scholar
• Ong CT, Khoo YT, Mukhopadhyay A et al. mTOR as a potential therapeutic target for treatment of keloids and excessive scars. Exp. Dermatol. 16(5), 394–404 (2007).
   PubMedGoogle Scholar
• Menke NB, Ward KR, Witten TM, Bonchev DG, Diegelmann RF. Impaired wound healing. Clin. Dermatol. 25(1), 19–25 (2007).
   PubMed Web of Science ®Google Scholar
• Menke MN, Menke NB, Boardman CH, Diegelmann RF. Biologic therapeutics and molecular profiling to optimize wound healing. Gynecol. Oncol. 111( 2 Suppl.), S87–91 (2008).
   PubMed Web of Science ®Google Scholar
• Widgerow AD. Chronic wound fluid--thinking outside the box. Wound Repair Regen. 19(3), 287–291 (2011).
   PubMed Web of Science ®Google Scholar
• Ladwig GP, Robson MC, Liu R, Kuhn MA, Muir DF, Schultz GS. Ratios of activated matrix metalloproteinase-9 to tissue inhibitor of matrix metalloproteinase-1 in wound fluids are inversely correlated with healing of pressure ulcers. Wound Repair Regen. 10(1), 26–37 (2002).
   PubMed Web of Science ®Google Scholar
• Conway K, Ruge F, Price P, Harding KG, Jiang WG. Hepatocyte growth factor regulation: an integral part of why wounds become chronic. Wound Repair Regen. 15(5), 683–692 (2007).
   PubMedGoogle Scholar
• Chmielowiec J, Borowiak M, Morkel M et al. c-Met is essential for wound healing in the skin. J. Cell Biol. 177(1), 151–162 (2007).
   PubMed Web of Science ®Google Scholar
• Zamboni P, De Mattei M, Ongaro A et al. Factor XIII contrasts the effects of metalloproteinases in human dermal fibroblast cultured cells. Vasc. Endovascular Surg. 38(5), 431–438 (2004).
   PubMedGoogle Scholar
• Gemmati D, Tognazzo S, Catozzi L et al. Influence of gene polymorphisms in ulcer healing process after superficial venous surgery. J. Vasc. Surg. 44(3), 554–562 (2006).
   PubMed Web of Science ®Google Scholar
• Gemmati D, Tognazzo S, Serino ML et al. Factor XIII V34L polymorphism modulates the risk of chronic venous leg ulcer progression and extension. Wound Repair Regen. 12(5), 512–517 (2004).
   PubMed Web of Science ®Google Scholar
• Heilborn JD, Nilsson MF, Kratz G et al. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 120(3), 379–389 (2003).
   PubMed Web of Science ®Google Scholar
• Yamasaki K, Schauber J, Coda A et al. Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin. FASEB J. 20(12), 2068–2080 (2006).
   PubMed Web of Science ®Google Scholar
• Morizane S, Yamasaki K, Kabigting FD, Gallo RL. Kallikrein expression and cathelicidin processing are independently controlled in keratinocytes by calcium, vitamin D(3), and retinoic acid. J. Invest. Dermatol. 130(5), 1297–1306 (2010).
   PubMed Web of Science ®Google Scholar
• Morizane S, Yamasaki K, Kajita A et al. TH2 cytokines increase kallikrein 7 expression and function in patients with atopic dermatitis. J. Allergy Clin. Immunol. 130(1), 259–261 (2012) e1.
   PubMed Web of Science ®Google Scholar
• Seitz O, Schurmann C, Hermes N et al. Wound healing in mice with high-fat diet- or ob gene-induced diabetes-obesity syndromes: a comparative study. Exp. Diabetes Res. 2010, 476969 (2010).
   PubMedGoogle Scholar
• Huijberts MS, Schaper NC, Schalkwijk CG. Advanced glycation end products and diabetic foot disease. Diabetes Metab. Res. Rev. 24( Suppl. 1), S19–S24 (2008).
   PubMedGoogle Scholar
• Niu YW, Miao MY, Dong W, Dong JY, Cao XZ, Lu SL. [Effects of advanced glycation end products and its receptor on oxidative stress in diabetic wounds]. Zhonghua Shao Shang Za Zhi. 28(1), 32–35 (2012).
   PubMedGoogle Scholar
• Frank S, Stallmeyer B, Kampfer H, Kolb N, Pfeilschifter J. Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J. Clin. Invest. 106(4), 501–509 (2000).
   PubMed Web of Science ®Google Scholar
• Frank S, Heni M, Moss A et al. Leptin therapy in a congenital leptin-deficient patient leads to acute and long-term changes in homeostatic, reward, and food-related brain areas. J. Clin. Endocrinol. Metab. 96(8), E1283–1287 (2011).
   PubMedGoogle Scholar
• Ubbink DT, Westerbos SJ, Nelson EA, Vermeulen H. A systematic review of topical negative pressure therapy for acute and chronic wounds. Br. J. Surg. 95(6), 685–692 (2008).
   PubMed Web of Science ®Google Scholar
• Ubbink DT, Westerbos SJ, Evans D, Land L, Vermeulen H. Topical negative pressure for treating chronic wounds. Cochrane Database Syst. Rev. (3), CD001898 (2008).
   Google Scholar
• Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst. Rev. (4), CD004123 (2012).
   Google Scholar
• Bhol KC, Schechter PJ. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. Br. J. Dermatol. 152(6), 1235–1242 (2005).
   PubMed Web of Science ®Google Scholar
• Murphy PS, Evans GR. Advances in wound healing: a review of current wound healing products. Plast. Surg. Int. 2012, 190436 (2012).
   PubMedGoogle Scholar
• Steinstraesser L, Koehler T, Jacobsen F et al. Host defense peptides in wound healing. Mol. Med. 14(7–8), 528–537 (2008).
   PubMed Web of Science ®Google Scholar
• Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J. Vasc. Surg. 21(1), 71–78, discussion 79–81 (1995).
   PubMed Web of Science ®Google Scholar
• Steed DL. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast. Reconstr. Surg. 117( 7 Suppl.), 143S–149S; discussion 150S–151S (2006).
   PubMed Web of Science ®Google Scholar
• Branski LK, Pereira CT, Herndon DN, Jeschke MG. Gene therapy in wound healing: present status and future directions. Gene Ther. 14(1), 1–10 (2007).
   PubMedGoogle Scholar
• Hardwicke J, Schmaljohann D, Boyce D, Thomas D. Epidermal growth factor therapy and wound healing--past, present and future perspectives. Surgeon 6(3), 172–177 (2008).
   PubMedGoogle Scholar
• Falanga V, Eaglstein WH, Bucalo B, Katz MH, Harris B, Carson P. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. J. Dermatol. Surg. Oncol. 18(7), 604–606 (1992).
   PubMedGoogle Scholar
• Vranckx JJ, Hoeller D, Velander PE et al. Cell suspension cultures of allogenic keratinocytes are efficient carriers for ex vivo gene transfer and accelerate the healing of full-thickness skin wounds by overexpression of human epidermal growth factor. Wound Repair Regen. 15(5), 657–664 (2007).
   PubMedGoogle Scholar
• Nanney LB, Woodrell CD, Greives MR et al. Calreticulin enhances porcine wound repair by diverse biological effects. Am. J. Pathol. 173(3), 610–630 (2008).
   PubMed Web of Science ®Google Scholar
• Sclafani AP, McCormick SA. Induction of dermal collagenesis, angiogenesis, and adipogenesis in human skin by injection of platelet-rich fibrin matrix. Arch. Facial Plast. Surg. 14(2), 132–136 (2012).
   PubMedGoogle Scholar
• Hom DB, Linzie BM, Huang TC. The healing effects of autologous platelet gel on acute human skin wounds. Arch. Facial Plast. Surg. 9(3), 174–183 (2007).
   PubMedGoogle Scholar
• Foulds IS, Barker AT. Human skin battery potentials and their possible role in wound healing. Br. J. Dermatol. 109(5), 515–522 (1983).
   PubMed Web of Science ®Google Scholar
• Li Q, Kao H, Matros E, Peng C, Murphy GF, Guo L. Pulsed radiofrequency energy accelerates wound healing in diabetic mice. Plast. Reconstr. Surg. 127(6), 2255–2262 (2011).
   PubMed Web of Science ®Google Scholar
• Qureshi AA, Ross KM, Ogawa R, Orgill DP. Shock wave therapy in wound healing. Plast. Reconstr. Surg. 128(6), 721e–727e (2011).
   PubMed Web of Science ®Google Scholar
• Ingber DE. Tensegrity-based mechanosensing from macro to micro. Prog. Biophys. Mol. Biol. 97(2–3), 163–179 (2008).
   PubMed Web of Science ®Google Scholar
• Wu Y, Huang S, Enhe J, Fu X. Insights into bone marrow-derived mesenchymal stem cells safety for cutaneous repair and regeneration. Int. Wound J. 9(6), 586–594 (2012).
   PubMedGoogle Scholar
• Paunescu V, Deak E, Herman D et al. In vitro differentiation of human mesenchymal stem cells to epithelial lineage. J. Cell Mol. Med. 11(3), 502–508 (2007).
   PubMed Web of Science ®Google Scholar
• Fathke C, Wilson L, Hutter J et al. Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells 22(5), 812–822 (2004).
   PubMed Web of Science ®Google Scholar
• Hong HS, Lee J, Lee E et al. A new role of substance P as an injury-inducible messenger for mobilization of CD29(+) stromal-like cells. Nat. Med. 15(4), 425–435 (2009).
   PubMed Web of Science ®Google Scholar
• Hong HS, Kim do Y, Yoon KJ, Son Y. A new paradigm for stem cell therapy: substance-P as a stem cell-stimulating agent. Arch. Pharm. Res. 34(12), 2003–2006 (2011).
   PubMedGoogle Scholar
• Hess CT. Clinical Guide to Skin & Wound Care (7th Edition). Wolters Kluwer Health/Lippincott Williams & Wilkins, Philadelphia, PA, USA (2013).
   Google Scholar